Home / ATXI : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ATXI make money? Does ATXI have pricing power? What's the Earnings Whisper? Will ATXI profit more as the business scales? What is ATXI's management track record? Is ATXI's current price justified?

Avenue Therapeutics, Inc.

$0.6 -$0.09 (-12.52%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.82

Day Range

$0.6$0.9

Year Range

$0.15$0.97

Market Cap

1.98M

AVG Volume

4.24K

Trailing/Forward PE

-0.71/-

PEG ratio

-0.03

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

Other OTC

Revenue (USD)

ATXI Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	1.4M
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD)

ATXI Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-690K
26 Q1	-695K
25 Q4	-709K
25 Q3	-683K
25 Q2	335K
25 Q1	-1.85M
24 Q4	-1.54M
24 Q3	-3.08M
24 Q2	-7.19M
24 Q1	-4.34M

Operating Income (USD)

ATXI Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-707K
26 Q1	-714K
25 Q4	-955K
25 Q3	-724K
25 Q2	297K
25 Q1	-1.91M
24 Q4	-1.6M
24 Q3	-3.16M
24 Q2	-2.82M
24 Q1	-3.71M

EBITDA (USD)

ATXI EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-707K
26 Q1	-714K
25 Q4	-955K
25 Q3	-683K
25 Q2	297K
25 Q1	-1.91M
24 Q4	-1.56M
24 Q3	-3.02M
24 Q2	-2.58M
24 Q1	-3.71M

Cash Flows (USD)

ATXI Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-475K
26 Q1	-438K
25 Q4	-854K
25 Q3	383K
25 Q2	-176K
25 Q1	-1.19M
24 Q4	-764K
24 Q3	-2.89M
24 Q2	-2.25M
24 Q1	-3.12M

EPS (USD)

ATXI EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.21
26 Q1	-0.21
25 Q4	-0.22
25 Q3	-0.21
25 Q2	0.11
25 Q1	-0.62
24 Q4	4.54
24 Q3	-1.92
24 Q2	-6.43
24 Q1	-7.72

Expenses (USD)

ATXI Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	707K
26 Q1	714K
25 Q4	954K
25 Q3	724K
25 Q2	1.11M
25 Q1	1.91M
24 Q4	1.6M
24 Q3	3.16M
24 Q2	2.82M
24 Q1	3.71M

Cash & Debt (USD)

ATXI Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	1.94M
26 Q1	2.42M
25 Q4	2.85M
25 Q3	3.71M
25 Q2	3.33M
25 Q1	3.5M
24 Q4	2.59M
24 Q3	2.6M
24 Q2	4.92M
24 Q1	3.19M

Debt ratios

ATXI Debt ratios by quarter
Period	Debt ratios
26 Q2	0.63
26 Q1	1.18
25 Q4	0.88
25 Q3	0.96
25 Q2	0.54
25 Q1	0.39
24 Q4	0.24
24 Q3	0.4
24 Q2	1.62
24 Q1	0.71

Margins

ATXI Margins by quarter
Period	Margins
25 Q2	100%

Return on Capital

ATXI Return on Capital by quarter
Period	Return on Capital
26 Q2	-121.27%
26 Q1	-58.01%
25 Q4	-38.7%
25 Q3	-29.66%
25 Q2	11.83%
25 Q1	-79.42%
24 Q4	-83.19%
24 Q3	-186.2%
24 Q2	-187.77%
24 Q1	-228.66%

Shares Outstanding

ATXI Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	3.29M
26 Q1	3.29M
25 Q4	3.13M
25 Q3	3.18M
25 Q2	3.18M
25 Q1	2.97M
24 Q4	1.6M
24 Q3	1.6M
24 Q2	1.12M
24 Q1	562.04K

Book Value Per Share (USD)

ATXI Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.17
26 Q1	0.36
25 Q4	0.59
25 Q3	0.72
25 Q2	0.89
25 Q1	0.78
24 Q4	1.16
24 Q3	1.03
24 Q2	3.42
24 Q1	3.38

Total Assets (USD)

ATXI Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	1.98M
26 Q1	2.47M
25 Q4	2.93M
25 Q3	3.73M
25 Q2	4.16M
25 Q1	3.59M
24 Q4	2.67M
24 Q3	2.62M
24 Q2	4.99M
24 Q1	3.31M

Employee Count

ATXI Employee Count by quarter
Period	Employee Count
2025	1
2024	2
2023	3
2022	2
2021	4
2020	4
2019	4
2018	6
2017	2

Free Cash Flow Yield

ATXI Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-70%
Sep 26	-77.14%
Aug 26	-92.93%
Aug 26	-163.06%
Aug 26	-163.06%
Aug 26	-164.65%
Jul 26	-84.97%
Jul 26	-119.51%
Jul 26	-131.77%
Jul 26	-103.33%
Jul 26	-108%
Jun 26	-117.65%
Jun 26	-101.19%
Jun 26	-102.94%
Jun 26	-93.45%
May 26	-109.8%
May 26	-136.75%
May 26	-109.8%
May 26	-62.15%
May 26	-96.28%
Apr 26	-88.7%
Apr 26	-106.44%
Apr 26	-130.09%
Apr 26	-167.26%
Mar 26	-188.79%
Mar 26	-188.79%
Mar 26	-228.13%
Mar 26	-248.86%
Feb 26	-288.16%
Feb 26	-365%
Feb 26	-365%
Feb 26	-285.77%
Jan 26	-271.04%
Jan 26	-135.32%
Jan 26	-78.21%
Jan 26	-73.2%
Jan 26	-79.82%
Dec 25	-85.31%
Dec 25	-83.99%
Dec 25	-84.19%
Dec 25	-71.2%
Nov 25	-71.61%
Nov 25	-70.27%
Nov 25	-72.03%
Nov 25	-210.01%
Oct 25	-218.79%
Oct 25	-221.78%
Oct 25	-215.76%
Oct 25	-221.84%
Oct 25	-225.04%
Sep 25	-196.91%
Sep 25	-207.25%
Sep 25	-192.11%
Sep 25	-214.32%
Aug 25	-276.37%
Aug 25	-271.6%
Aug 25	-276.37%
Aug 25	-478.99%
Aug 25	-518.93%
Jul 25	-600.98%
Jul 25	-568.35%
Jul 25	-653.99%
Jul 25	-702.29%
Jun 25	-992.96%
Jun 25	-799.02%
Jun 25	-1146.81%
Jun 25	-918.11%
May 25	-1095.74%
May 25	-1143.34%
May 25	-1084.54%
May 25	-2350.52%
May 25	-2238.59%
Apr 25	-2238.59%
Apr 25	-2128.37%
Apr 25	-2168.96%
Apr 25	-2168.04%
Mar 25	-2127.48%
Mar 25	-1827.69%
Mar 25	-837.5%
Mar 25	-675.13%
Feb 25	-601.48%
Feb 25	-486.49%
Feb 25	-486.49%
Feb 25	-542.32%
Jan 25	-486.49%
Jan 25	-350.07%
Jan 25	-357.64%
Jan 25	-365.54%
Jan 25	-321.18%
Dec 24	-341.04%
Dec 24	-373.8%
Dec 24	-367.57%
Dec 24	-359.58%
Nov 24	-307.73%
Nov 24	-329.17%
Nov 24	-342.81%
Nov 24	-391.52%
Nov 24	-382.78%
Oct 24	-389.74%
Oct 24	-406.36%

Price to Sales

ATXI Price to Sales by quarter
Period	Price to Sales
Jul 26	0.91
Jul 26	0.65
Jul 26	0.59
Jul 26	0.75
Jul 26	0.72
Jun 26	0.66
Jun 26	0.76
Jun 26	0.75
Jun 26	0.83
May 26	0.7
May 26	0.57
May 26	0.7
May 26	1.24
May 26	1.36
Apr 26	1.47
Apr 26	1.23
Apr 26	1
Apr 26	0.78
Mar 26	0.66
Mar 26	0.66
Mar 26	0.54
Mar 26	0.5
Feb 26	0.43
Feb 26	0.34
Feb 26	0.34
Feb 26	0.43
Jan 26	0.46
Jan 26	0.92
Jan 26	1.59
Jan 26	1.7
Jan 26	1.56
Dec 25	1.46
Dec 25	1.48
Dec 25	1.47
Dec 25	1.74
Nov 25	1.73
Nov 25	1.77
Nov 25	1.72
Nov 25	1.7
Oct 25	1.63
Oct 25	1.61
Oct 25	1.66
Oct 25	1.61
Oct 25	1.59
Sep 25	1.81
Sep 25	1.72
Sep 25	1.86
Sep 25	1.67
Aug 25	1.29
Aug 25	1.32
Aug 25	1.29

EV/EBITDA

ATXI EV/EBITDA by quarter
Period	EV/EBITDA
May 23	1438.3
Apr 23	1339.38
Apr 23	1452.42
Apr 23	1537.09
Apr 23	1748.79
Mar 23	1642.94

Price to Book

ATXI Price to Book by quarter
Period	Price to Book
Sep 26	3.47
Sep 26	3.15
Aug 26	2.62
Aug 26	1.49
Aug 26	1.49
Aug 26	1.48
Jul 26	1.07
Jul 26	0.76
Jul 26	0.69
Jul 26	0.88
Jul 26	0.84
Jun 26	0.77
Jun 26	0.9
Jun 26	0.88
Jun 26	0.97
May 26	0.82
May 26	0.66
May 26	0.82
May 26	1.46
May 26	1.04
Apr 26	1.13
Apr 26	0.94
Apr 26	0.77
Apr 26	0.6
Mar 26	0.4
Mar 26	0.4
Mar 26	0.33
Mar 26	0.3
Feb 26	0.26
Feb 26	0.21
Feb 26	0.21
Feb 26	0.26
Jan 26	0.28
Jan 26	0.56
Jan 26	0.97
Jan 26	1.03
Jan 26	0.95
Dec 25	0.89
Dec 25	0.9
Dec 25	0.9
Dec 25	1.06
Nov 25	1.06
Nov 25	1.08
Nov 25	1.05
Nov 25	0.84
Oct 25	0.81
Oct 25	0.8
Oct 25	0.82
Oct 25	0.8
Oct 25	0.79
Sep 25	0.9
Sep 25	0.85
Sep 25	0.92
Sep 25	0.83
Aug 25	0.64
Aug 25	0.65
Aug 25	0.64
Aug 25	0.63
Aug 25	0.59
Jul 25	0.51
Jul 25	0.54
Jul 25	0.47
Jul 25	0.43
Jun 25	0.31
Jun 25	0.38
Jun 25	0.27
Jun 25	0.33
May 25	0.28
May 25	0.27
May 25	0.28
May 25	0.21
May 25	0.22
Apr 25	0.22
Apr 25	0.23
Apr 25	0.22
Apr 25	0.22
Mar 25	0.3
Mar 25	0.35
Mar 25	0.77
Mar 25	0.95
Feb 25	1.07
Feb 25	1.32
Feb 25	1.32
Feb 25	1.18
Jan 25	1.32
Jan 25	1.83
Jan 25	1.79
Jan 25	1.75
Jan 25	2
Dec 24	1.88
Dec 24	1.71
Dec 24	1.74
Dec 24	1.78
Nov 24	2.08
Nov 24	1.95
Nov 24	1.87
Nov 24	0.64
Nov 24	0.65
Oct 24	0.64
Oct 24	0.62

No video analysis for this stock yet. Request one from our team.

News: ATXI

defenseworld.net · 13 Aug 2026

Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey

Collegium Pharmaceutical (NASDAQ: COLL - Get Free Report) and Avenue Therapeutics (NASDAQ: ATXI - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares Collegium Pharmaceutical and

AI Analysis

Avenue Therapeutics, Inc.

Video analysis: ATXI

News: ATXI

Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey

Similar companies